Cat. No.: X23-12-YM759

Ponesimod

Synonym: 854107-55-4; ACT-128800

  • CAS Number: 854107-55-4
  • Compound CID: 11363176
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Ponesimod, soluble in DMSO and ethanol and insoluble in water, inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets S1P1 receptor.
Molecular Weight
460.97
Molecular Formula
C23H25ClN2O4S
Targets
S1P1 receptor: 5.7 nM (EC50)
Form
Lyophilized powder
Purity
>98%
Solubility
DMSO: 82 mg/mL (177.88 mM); Water: insoluble; Ethanol: 82 mg/mL
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Ponesimod can be used for its ability to retain certain white blood cells (lymphocytes) within the lymph nodes, thereby preventing their migration into the central nervous system where they can contribute to inflammation and damage.
Storage
Store at -20°C, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.